Literature DB >> 17161349

Influence of bradykinin B1 and B2 receptors in the immune response triggered by renal ischemia-reperfusion injury.

Pamella Huey Mei Wang1, Marcos Antonio Cenedeze, João Bosco Pesquero, Alvaro Pacheco-Silva, Niels Olsen Saraiva Câmara.   

Abstract

Bradykinin B1 receptors are exclusively expressed in inflamed tissues. For this reason, they have been related with the outcomes of several pathologies. Ischemia-reperfusion injury is caused by the activation of inflammatory and cytoprotective genes, such as macrophage chemoattractant protein-1 and heme oxygenase-1, respectively. This study was aimed to analyze the involvement of bradykinin B1 and B2 receptors (B1R and B2R) in tissue response after renal ischemia-reperfusion injury. For that, B1R (B1-/-), B2R (B2-/-) knockout animals and its control (wild-type mice, B1B2+/+) were subjected to renal bilateral ischemia, followed by 24, 48 and 120 h of reperfusion. At these time points, blood serum samples were collected for creatinine and urea dosages. Kidneys were harvested for histology and molecular analyses by real-time PCR. At 24 and 48 h of reperfusion, B1-/- group resulted in the lowest serum creatinine and urea levels, indicating less renal damage, which was proved by renal histology. Renal protection associated with B1-/- mice was also related with higher expression of HO-1 and lower expression of MCP-1. In conclusion, the absence of B1R had a protective role against inflammatory responses developed after renal ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161349     DOI: 10.1016/j.intimp.2006.07.031

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  8 in total

1.  Kinin B1 receptor deficiency attenuates cisplatin-induced acute kidney injury by modulating immune cell migration.

Authors:  Gabriel R Estrela; Frederick Wasinski; Danilo C Almeida; Mariane T Amano; Angela Castoldi; Carolina C Dias; Denise M A C Malheiros; Sandro S Almeida; Edgar J Paredes-Gamero; João B Pesquero; Carlos C Barros; Niels O S Câmara; Ronaldo C Araújo
Journal:  J Mol Med (Berl)       Date:  2013-12-20       Impact factor: 4.599

Review 2.  Immunobiology of spinal cord injuries and potential therapeutic approaches.

Authors:  Aabra Ahmed; Arun-Angelo Patil; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2017-09-07       Impact factor: 3.396

3.  MATE-1 modulation by kinin B1 receptor enhances cisplatin efflux from renal cells.

Authors:  Gabriel R Estrela; Frederick Wasinski; Raphael J F Felizardo; Laura L Souza; Niels O S Câmara; Michael Bader; Ronaldo C Araujo
Journal:  Mol Cell Biochem       Date:  2017-02-04       Impact factor: 3.396

4.  Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury.

Authors:  Masao Kakoki; Robert W McGarrah; Hyung-Suk Kim; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

Review 5.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

6.  Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice.

Authors:  Juan S Danobeitia; Martynas Ziemelis; Xiaobo Ma; Laura J Zitur; Tiffany Zens; Peter J Chlebeck; Edwin S Van Amersfoort; Luis A Fernandez
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

7.  The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCR-mediated pathways of host cell invasion by Trypanosoma cruzi.

Authors:  Julio Scharfstein; Daniele Andrade; Erik Svensjö; Ana Carolina Oliveira; Clarissa R Nascimento
Journal:  Front Immunol       Date:  2013-01-25       Impact factor: 7.561

8.  Bradykinin [corrected] B1 receptor antagonism is beneficial in renal ischemia-reperfusion injury.

Authors:  Pamella H M Wang; Gabriela Campanholle; Marcos A Cenedeze; Carla Q Feitoza; Giselle M Gonçalves; Richardt G Landgraf; Sonia Jancar; João B Pesquero; Alvaro Pacheco-Silva; Niels O S Câmara
Journal:  PLoS One       Date:  2008-08-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.